Polysorbate 80 vs Carrageenan: which is worse?

What is Polysorbate 80?

Polysorbate 80 (Tween 80) is a synthetic nonionic surfactant and emulsifier derived from sorbitol and oleic acid (from vegetable oils) through ethoxylation. It is widely used in food to keep water-based and oil-based ingredients uniformly mixed. Chemical formula: polyoxyethylene (20) sorbitan monooleate.

What is Carrageenan?

Carrageenan is a polysaccharide extracted from red seaweed (primarily Chondrus crispus and Eucheuma species). Used as a thickener, gelling agent, and stabilizer in food and personal care products. Food-grade carrageenan (undegraded) is different from degraded carrageenan (poligeenan), which is not food-grade and is a known inflammatory agent.

Documented risks

Polysorbate 80: Emerging research has raised concerns about polysorbate 80's effects on the gut. A landmark 2015 study in Nature (Chassaing et al.) found that dietary polysorbate 80 and polysorbate 60 at concentrations approaching food use levels promoted colitis and metabolic syndrome in genetically susceptible mice by disrupting the intestinal mucus layer and altering gut microbiome composition. The emulsifiers thinned the protective mucus layer, allowing bacteria to come into closer contact with gut epithelial cells and triggering inflammation. This study was a seminal contribution to gut health research, though it was conducted in mice and requires confirmation in humans. A 2020 follow-up study found that dietary emulsifiers including polysorbate 80 promoted gut inflammation and altered gut microbiome in human participants with Crohn's disease. People with inflammatory bowel disease may be most vulnerable to polysorbate 80's potential gut effects.

Carrageenan: Carrageenan safety has been disputed for decades, centering on the distinction between undegraded (food-grade, high-molecular-weight) carrageenan and degraded carrageenan (poligeenan). Poligeenan, produced by acid hydrolysis, is a known inflammatory and carcinogenic agent in animals. Food-grade carrageenan is a different molecule, but critics argue it can partially degrade in the acidic stomach environment. Dr. Joanne Tobacman at the University of Illinois has published multiple studies on carrageenan-induced inflammation. A 2001 paper in Environmental Health Perspectives (PMC1240867) demonstrated that food-grade carrageenan activates inflammatory signaling pathways (NF-κB) in human intestinal cells, inhibits insulin signaling, and causes intestinal injury in animal models. Her 2012 review in the Journal of Diabetes Research summarized multiple animal studies showing intestinal inflammation, ulcerations, and neoplasms. A 2017 review in Environmental Health Perspectives (Bhide et al.) found carrageenan activated NF-κB inflammatory pathways and could potentially exacerbate inflammatory bowel disease (IBD) in susceptible individuals. Major regulatory bodies including EFSA (comprehensive 2018 re-evaluation) and the WHO/FAO JECFA have consistently concluded that undegraded food-grade carrageenan does not cause cancer or significant harm at typical food use levels in healthy adults. However, the EU precautionary ban in infant formula (2018) acknowledged that infants' developing digestive systems may be more vulnerable to carrageenan's potential effects, and insufficient evidence of safety existed for this specific high-risk population. The USDA's removal of carrageenan from Organic certification (2018) reflected organic industry stakeholder concern despite the continued regulatory permission. Individuals with IBD or gut sensitivity may have reason to avoid carrageenan based on in vitro and animal data, even if the general population safety at food use levels is defended by EFSA and JECFA.